Pfizer and BioNTech seek authorization of second coronavirus booster shot for people 65 and older
The Washington Post (15 March, 2022) – Pharmaceutical giant Pfizer and its partner, BioNTech, filed Tuesday for emergency authorization of a second booster shot of their coronavirus vaccine for people 65 and older, an effort to bolster waning immunity that occurs several months after the first booster, the companies announced.